Related Experiment Video

Updated: Jul 4, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Sinusoidal Obstruction Syndrome With Inotuzumab Ozogamicin Combined With Ponatinib for

Emi Yokoyama1, Satoshi Ota2, Yasuo Sakurai3,4

  • 1Blood Disorders Center Aiiku Hospital Sapporo Japan.

Ejhaem
|July 3, 2026
PubMed
Abstract

Keywords:
Philadelphia‐chromosome‐positive lymphoid malignanciesinotuzumab ozogamicinponatinibsinusoidal obstruction syndromeveno‐occlusive disease

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...